Showing results (181-190 of 223) with videos related to

Sort By:
Pageof 23
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 29, 2022
Long-term safety and efficacy of ozanimod in relapsing multiple sclerosis: Up to 5 years of follow-up in the DAYBREAK open-label extension trialBruce Ac Cree, Krzysztof W Selmaj, Lawrence Steinman, et al.
Multiple Sclerosis and Related Disorders|May 30, 2025
Genetic diseases misdiagnosed as multiple sclerosis: Observational study and review of literatureDaniele Mandia, Natalia Shor, Alise K Carlson, et al.
The New England Journal of Medicine|January 22, 2010
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosisJeffrey A Cohen, Frederik Barkhof, Giancarlo Comi, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|October 11, 2024
Pharmacokinetics and Pharmacodynamics of Natalizumab 6-Week Dosing vs Continued 4-Week Dosing for Relapsing-Remitting Multiple SclerosisJohn F Foley, Gilles Defer, Lana Zhovtis Ryerson, et al.
Neurology. Clinical Practice|September 6, 2021
Consensus Curriculum for Fellowship Training in Multiple Sclerosis and NeuroimmunologyLe H Hua, Ahmed Z Obeidat, Lilyana Amezcua, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 23, 2025
Brain atrophy and associations with long-term disability and cognitive function in participants with relapsing multiple sclerosis treated with ozanimod: Results from phase 3 and open-label extension trialsJeffrey A Cohen, Douglas L Arnold, John DeLuca, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 7, 2022
Immunoglobulin G immune response to SARS-CoV-2 vaccination in people living with multiple sclerosis within Multiple Sclerosis Partners Advancing Technology and Health SolutionsJeffrey A Cohen, Robert A Bermel, Cynthia I Grossman, et al.
Archives of Physical Medicine and Rehabilitation|January 11, 2005
Distal symmetrical polyneuropathy: a definition for clinical research. A report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and RehabilitationJohn D England, Gary S Gronseth, Gary Franklin, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 7, 2017
Pilot trial of intravenous autologous culture-expanded mesenchymal stem cell transplantation in multiple sclerosisJeffrey A Cohen, Peter B Imrey, Sarah M Planchon, et al.
The Lancet. Neurology|September 20, 2024
Differential diagnosis of suspected multiple sclerosis: considerations in people from minority ethnic and racial backgrounds in North America, northern Europe, and AustralasiaLilyana Amezcua, Dalia Rotstein, Afsaneh Shirani, et al.
Pageof 23